Home » Topics » BioWorld Science

BioWorld Science
RSS

Xalud initiates phase I trial of XT-150 for osteoarthritic pain

June 21, 2018

Kiyatec initiates 3D-PREDICT study with EV3D assay

June 21, 2018

PATH and SD Biosensor partner on new diagnostic for G6PD deficiency in malaria

June 21, 2018

FDA approves use of Cinryze to prevent angioedema attacks in pediatric patients with HAE

June 21, 2018

Immune Design opens phase III study of CMB-305 for synovial sarcoma

June 21, 2018

Atossa completes dosing in phase I study of topical endoxifen

June 21, 2018

New phase II trial studies arimoclomol for Gaucher's disease

June 21, 2018

Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs

June 21, 2018

Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome

June 21, 2018

GSX2 gene identified as causative of basal ganglia agenesis

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...